Target intelligence / Profile preview

Damage-associated molecular patterns (DAMPs) and Pathogen-associated molecular patterns (PAMPs) (DAMPs and PAMPs)

Target
DAMPs and PAMPs
Molecular classification
Ligands, Pattern recognition receptor ligands, Danger signals, Alarmins
01

Overview

Damage-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs) are diverse sets of molecules that serve as "danger signals" to initiate and perpetuate the innate immune response [1]. PAMPs are highly conserved molecular structures produced by microorganisms, such as lipopolysaccharides (LPS) from bacteria or viral double-stranded RNA, which are recognized as foreign by the host [2]. In contrast, DAMPs are endogenous molecules, such as High mobility group box 1 (HMGB1), S100 proteins, or extracellular ATP, that are released or exposed following cellular stress, injury, or non-programmed cell death [3]. Both classes of molecules exert their biological effects by binding to pattern recognition receptors (PRRs), including Toll-like receptors (TLRs) and NOD-like receptors (NLRs), triggering signaling cascades that lead to the production of pro-inflammatory cytokines and type I interferons [4]. In clinical contexts, the dysregulation or chronic presence of DAMPs and PAMPs is central to the pathogenesis of sepsis, autoimmune disorders, and chronic inflammatory diseases [2]. Therapeutic strategies often focus on neutralizing specific DAMPs/PAMPs or antagonizing their respective PRRs to mitigate excessive inflammation, though such interventions must balance the need for immune suppression with the risk of opportunistic infections [5].

Other names
Danger signalsAlarminsMicrobe-associated molecular patterns (MAMPs)Xenofactors
02

Mechanism of action

Neutralization of circulating ligands or blockade of their cognate pattern recognition receptors (PRRs) to inhibit downstream pro-inflammatory signaling pathways.

03

Biological functions

Immune responseInflammationSignal transductionTissue repairPhagocytosisApoptosis
04

Disease associations

SepsisInfectionInflammationAutoimmune diseaseCancerCardiovascular diseaseIschemia-reperfusion injury
05

Safety considerations

Increased risk of opportunistic infectionsImpaired wound healing and tissue repairPotential for systemic immunosuppression
06

Interacting drugs

Polymyxin B

4 more in the full profile.

07

Biomarkers

High mobility group box 1 (HMGB1)S100 calcium-binding protein A8/A9 (Calprotectin)Cell-free DNA (cfDNA)Mitochondrial DNA (mtDNA)Procalcitonin (PCT)

Beyond the preview

Go deeper on Damage-associated molecular patterns (DAMPs) and Pathogen-associated molecular patterns (PAMPs) (DAMPs and PAMPs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Damage-associated molecular patterns (DAMPs) and Pathogen-associated molecular patterns (PAMPs) (DAMPs and PAMPs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call